Food & Drug Law

Mason Marks & I. Glenn Cohen, How Should the FDA Evaluate Psychedelic Medicine?, 389 New England J. Med. 1733 (2023).

Mason Marks, I. Glenn Cohen, Jonathan Perez- Reyzin et al., Microdosing Psychedelics Under Local, State, and Federal Law, 103 B.U. L. Rev. 101 (2023).

Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional, Am. J. Med.

Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, Drug Importation from Canada: The Wrong Prescription, 106 R.I. Med. J. 56 (2023).

Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The Inflation Reduction Act: Recasting the Medicare Prescription Drug Plans, Am. J. Preventative Med. (2023).

Eli Y. Adashi & I. Glenn Cohen, The FDA Initiative to Assure Racial and Ethnic Diversity in Clinical Trials, 36 J. Am. Bd. Fam. Med.

Jacob S. Sherkow, Eli Y. Adashi & I. Glenn Cohen, Assessing—and Extending—California’s Insulin Manufacturing Initiative, JAMA (2023).

Patricia J. Zettler, Eli Y. Adashi & I. Glenn Cohen, Alliance for Hippocratic Medicine v. FDA — Dobbs’s Collateral Consequences for Pharmaceutical Regulation, 388 New…

Daniel G. Aaron, I. Glenn Cohen & Eli Y. Adashi, The FDA Struggle to Withdraw Makena, JAMA (2022).

Eli Y. Adashi & I. Glenn Cohen, Integrity of SARS-CoV-2 Laboratory-Developed Tests—Reply, 328 JAMA 478 (2022).

Eli Y. Adashi & I. Glenn Cohen, Capping Prescription Drug Costs: State Initiatives to the Rescue?, 105 R.I. Med. J. 53 (2022).

Winston McCormick, Eli Y. Adashi & I. Glenn Cohen, Expanding the Blood Pool: The Limitations of the FDA’S Current MSM Blood Deferral, 97 Mayo Clinic…

Eli Y. Adashi & I. Glenn Cohen, The CMS Vaccine Mandate at the Supreme Court: A Hippocratic Imperative, Am. J. Med. (2022).

Georgia R. Goodman et al., “I’d feel like someone was watchin’ me… watching for a good reason”: Perceptions of data privacy, access, and sharing in…

Eli Y. Adashi & I. Glenn Cohen, SARS-CoV-2 Laboratory-Developed Tests, JAMA (2022).

Eli Y. Adashi et al., The next two decades of mifepristone at FDA: History as destiny, Contraception (2022).

David A. Simon, Carmel Shachar & I. Glenn Cohen, At-home Diagnostics and Diagnostic Excellence: Devices vs General Wellness Products, 327 JAMA 523 (2022).

Eli Y. Adashi, Katina M. Robison & I. Glenn Cohen, Deadly Legacy-The 510(k) Path toMedical Device Clearance, 157 JAMA Surgery 185 (2021).

Mason Marks & I. Glenn Cohen, Patents on Psychedelics: The Next Legal Battlefront of Drug Development, 135 Harv. L. Rev. F. (2022).

Kerry Lynn Macintosh, I. Glenn Cohen, Jacob. S. Sherkow & Eli Y. Adashi, Gene Editing Sperm and Eggs for Use in Clinical Trials – The…

Patricia J. Zettler, Eli Y. Adashi & I. Glenn Cohen, A Divisive Ruling on Devices – Genus Medical Technologies v. FDA, 385 New England J.